Suchergebnisse - "Pérez-Sempere, Ángel"

PubPharm (21)

1

Dyspnea and Bronchoconstriction in a Young Patient With Multiple Sclerosis Treated With Ponesimod

enthalten in: Archivos de bronconeumologia | 2023

von Gómez Román, M. | García Ródenas, M. | Moreno Navarro, L. | +2

2

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis

enthalten in: JAMA neurology | 2023

von Kalincik, T. | Sharmin, S. | Roos, I. | +153

CommentIn: JAMA Neurol. 2023 Jul 1;80(7):669-672. - PMID 37184849

3

Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis

enthalten in: European journal of neurology | 2023

von Diouf, I. | Malpas, C. | Sharmin, S. | +79

4

Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis

enthalten in: European Journal of Neurology | 2023

von Diouf, I. | Malpas, C. | Sharmin, S. | +79

5

Machine-learning-based prediction of disability progression in multiple sclerosis: an observational, international, multi-center study

enthalten in: bioRxiv.org | 2022

von De Brouwer, E. | Becker, T. | Werthen-Brabants, L. | +70

6

SARS-CoV-2 Infection in Multiple Sclerosis : Results of the Spanish Neurology Society Registry

enthalten in: Neurology(R) neuroimmunology & neuroinflammation | 2021

von Arrambide, G. | Llaneza-González, M. | Costa-Frossard França, L. | +37

7

Discontinuation of disease-modifying treatments in multiple sclerosis to plan a pregnancy : A retrospective registry study

enthalten in: Multiple sclerosis and related disorders | 2020

von Villaverde-González, R. | Candeliere-Merlicco, A. | Alonso-Frías, M. | +4

8

A general presentation on how to carry out a CHARMS analysis for prognostic multivariate models

enthalten in: Statistics in medicine | 2020

von Palazón-Bru, A. | Martín-Pérez, F. | Mares-García, E. | +4

9

Clusters of Cardiovascular Risk Factors and Their Impact on the 20-Year Cardiovascular Risk in a General Population

enthalten in: The Journal of cardiovascular nursing | 2020

von Palazón-Bru, A. | Ferri-Rufete, D. | Mares-García, E. | +10

10

Effectiveness of Fingolimod versus Natalizumab as Second-Line Therapy for Relapsing-Remitting Multiple Sclerosis in Spain : Second-Line GATE Study

enthalten in: European neurology | 2020

von Meca-Lallana, J. | Ayuso, T. | Martínez-Yelamos, S. | +9